<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00162578</url>
  </required_header>
  <id_info>
    <org_study_id>LMR4</org_study_id>
    <nct_id>NCT00162578</nct_id>
  </id_info>
  <brief_title>Vancomycin Concentration in Cerebrospinal Fluid During Pneumococcal Meningitis</brief_title>
  <official_title>Vancomycin Concentration in Cerebrospinal Fluid During Pneumococcal Meningitis Treated With Dexamethasone</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adding vancomycin to the antibiotic regimen is recommended for the treatment of pneumococcal
      meningitis in adults. Use of dexamethasone as adjunct therapy has proved to reduce mortality
      and neurologic sequelae in adult patients with pneumococcal meningitis. However, use of
      dexamethasone may impair penetration of vancomycin in cerebrospinal fluid. In a purely
      observational manner, we thought to measure blood and CSF concentrations of vancomycin in
      adult patients with pneumococcal meningitis, treated with vancomycin, third-generation
      cephalosporin and dexamethasone.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Because of a considerable increase in streptococcus pneumoniae meningitis with penicillin
      nonsusceptible strains, it is now largely recommended to add vancomycin to the
      third-generation cephalosporin antibiotic regimen. It has also been recently shown that use
      of dexamethasone reduces mortality and unfavorable outcome in adults with pneumococcal
      meningitis. However, concern has arisen, that dexamethasone may impair penetration of
      vancomycin in cerebrospinal fluid.

      We therefore thought to measure in a purely observational study, blood and CSF vancomycin
      concentrations in adult patients with pneumococcal meningitis hospitalized in medical
      intensive care unit that received third-generation cephalosporin, vancomycin and
      dexamethasone. The aim of the study was to observe whether or not sufficient concentrations
      of vancomycin could be measured in the CSF despite the concomitant use of dexamethasone.
      Patients were cared for in a perfectly routine manner. There was no randomization. All
      patients received routine, recommended care (IDSA guidelines). There was no invasive
      procedure. Dexamethasone was administered according to the de Gans study (NEJM 2002). In
      these patients with severe meningitis, a second lumbar puncture was performed as
      recommended(IDSA Guidelines, CID 2004). At the same time, peripheral blood was taken. In both
      samples, vancomycin concentration was determined.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2002</start_date>
  <completion_date type="Actual">November 2005</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Defined Population, Natural History</observational_model>
    <time_perspective>Longitudinal, Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">14</enrollment>
  <condition>Pneumococcal Meningitis</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults (&gt; 18 yr) with suspicion of pneumococcal meningitis requiring intensive care
             unit

        Exclusion Criteria:

          -  Allergy to one of the antibiotics used in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Damien Ricard, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Didier DREYFUSS, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Service de Réanimation Médicale, CHU Louis Mourier</name>
      <address>
        <city>Colombes</city>
        <zip>92700</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Réanimation Médicale, CHU Bichat</name>
      <address>
        <city>Paris</city>
        <zip>75018</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Réanimation Médicale, CHI Poissy-St-Germain</name>
      <address>
        <city>Poissy</city>
        <zip>78300</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, Whitley RJ. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004 Nov 1;39(9):1267-84. Epub 2004 Oct 6.</citation>
    <PMID>15494903</PMID>
  </reference>
  <reference>
    <citation>de Gans J, van de Beek D; European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators. Dexamethasone in adults with bacterial meningitis. N Engl J Med. 2002 Nov 14;347(20):1549-56.</citation>
    <PMID>12432041</PMID>
  </reference>
  <reference>
    <citation>Auburtin M, Porcher R, Bruneel F, Scanvic A, Trouillet JL, Bédos JP, Régnier B, Wolff M. Pneumococcal meningitis in the intensive care unit: prognostic factors of clinical outcome in a series of 80 cases. Am J Respir Crit Care Med. 2002 Mar 1;165(5):713-7.</citation>
    <PMID>11874820</PMID>
  </reference>
  <reference>
    <citation>Viladrich PF, Gudiol F, Liñares J, Pallarés R, Sabaté I, Rufí G, Ariza J. Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrob Agents Chemother. 1991 Dec;35(12):2467-72.</citation>
    <PMID>1810180</PMID>
  </reference>
  <verification_date>July 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 9, 2005</study_first_submitted>
  <study_first_submitted_qc>September 9, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 13, 2005</study_first_posted>
  <last_update_submitted>July 20, 2007</last_update_submitted>
  <last_update_submitted_qc>July 20, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 23, 2007</last_update_posted>
  <keyword>pneumococcal meningitis</keyword>
  <keyword>intensive care unit</keyword>
  <keyword>vancomycin</keyword>
  <keyword>dexamethasone</keyword>
  <keyword>drug diffusion in cerebrospinal fluid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Meningitis</mesh_term>
    <mesh_term>Meningitis, Pneumococcal</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Vancomycin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

